User menu

Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation

Bibliographic reference Sessink, Paul JM ; Leclercq, Gisèle ; Wouters, Dominique Marie ; Halbardier, Loïc ; Hammad, Chaïma ; et. al. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation. In: Journal of Oncology Pharmacy Practice, Vol. 21, no. 2, p. 118-127 (2014)
Permanent URL
  1. ASHP Guidelines on Handling Hazardous Drugs, 10.2146/ajhp050529
  2. Connor Thomas H., DeBord D. Gayle, Pretty Jack R., Oliver Marc S., Roth Tracy S., Lees Peter S. J., Krieg Edward F., Rogers Bonnie, Escalante Carmen P., Toennis Christine A., Clark John C., Johnson Belinda C., McDiarmid Melissa A., Evaluation of Antineoplastic Drug Exposure of Health Care Workers at Three University-Based US Cancer Centers : , 10.1097/jom.0b013e3181f72b63
  3. Yoshida Jin, Koda Shigeki, Nishida Shozo, Yoshida Toshiaki, Miyajima Keiko, Kumagai Shinji, Association between occupational exposure levels of antineoplastic drugs and work environment in five hospitals in Japan, 10.1177/1078155210380485
  4. Turci Roberta, Minoia Claudio, Sottani Cristina, Coghi Raffaella, Severi Paolo, Castriotta Cecilia, Del Bianco Massimo, Imbriani Marcello, Occupational exposure to antineoplastic drugs in seven Italian hospitals: The effect of quality assurance and adherence to guidelines, 10.1177/1078155210381931
  5. Sessink Paul J.M., Bos Rob P., Drugs Hazardous to Healthcare Workers : Evaluation of Methods for Monitoring Occupational Exposure to Cytostatic Drugs, 10.2165/00002018-199920040-00004
  6. Acampora A, Ann Occup Hyg, 49, 611 (2005)
  7. Connor TH, Am J Health Syst Pharm, 56, 1427 (1999)
  8. Crauste-Manciet S, Ann Occup Hyg, 49, 619 (2005)
  9. Favier B, J Pharm Clin, 20, 157 (2001)
  10. Hedmer M, Ann Occup Hyg, 49, 629 (2005)
  11. Kromhout H, Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys, 10.1016/s0003-4878(00)00050-8
  12. Leboucher G, Bull Cancer, 89, 949 (2002)
  13. McDevitt JJ, J Occup Med, 35, 57 (1993)
  14. Micoli Giuseppina, Turci Roberta, Arpellini Marta, Minoia Claudio, Determination of 5-fluorouracil in environmental samples by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection, 10.1016/s0378-4347(00)00377-7
  15. Minoia Claudio, Turci Roberta, Sottani Cristina, Schiavi Angelo, Perbellini Luigi, Angeleri Sergio, Draicchio Francesco, Apostoli Pietro, Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide, 10.1002/(sici)1097-0231(19981030)12:20<1485::aid-rcm333>;2-n
  16. Ros JJW, Ziekenhuisfarmacie, 13, 168 (1997)
  17. Rubino FM, Med Lav, 90, 572 (1999)
  18. Schmaus G, Am J Health Syst Pharm, 59, 956 (2002)
  19. Sessink PJM, Pharm Week Sci, 14, 16 (1992)
  20. Sessink P. J. M., Friem�l N. S. S., Anzion R. B. M., Bos R. P., Biological and environmental monitoring of occupational exposure of pharmaceutical plant workers to methotrexate, 10.1007/bf00383251
  21. Sessink Paul J.M., Wittenhorst Barry C.J., Anzion Rob B.M., Bos Rob P., Exposure of Pharmacy Technicians to Antineoplastic Agents: Reevaluation after Additional Protective Measures, 10.1080/00039899709602893
  22. Sorsa Marja, Pyy Lauri, Salomaa Sisko, Nylund Lars, Yager Janice W., Biological and environmental monitoring of occupational exposure to cyclophosphamide in industry and hospitals, 10.1016/0165-1218(88)90042-0
  23. Sottani Cristina, Turci Roberta, Perbellini Luigi, Minoia Claudio, Liquid-liquid extraction procedure for trace determination of cyclophosphamide in human urine by high-performance liquid chromatography tandem mass spectrometry, 10.1002/(sici)1097-0231(19980831)12:16<1063::aid-rcm287>;2-k
  24. Stuart O. Anthony, Stephens Arvil D., Welch Laura, Sugarbaker Paul H., Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C, 10.1007/bf02557372
  25. Turci Roberta, Micoli Giuseppina, Minoia Claudio, Determination of methotrexate in environmental samples by solid phase extraction and high performance liquid chromatography: ultraviolet or tandem mass spectrometry detection?, 10.1002/(sici)1097-0231(20000430)14:8<685::aid-rcm937>;2-2
  26. Turci Roberta, Sottani Cristina, Spagnoli Giuseppe, Minoia Claudio, Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods, 10.1016/s1570-0232(03)00100-4
  27. Zeedijk M, Eur J Hosp Pharm, 1, 18 (2005)
  28. Harrison B. R., Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques, 10.2146/ajhp050258
  29. Hirst Maurice, Mills DonaldG., Tse Sandy, Levin Leslie, White DavidF., OCCUPATIONAL EXPOSURE TO CYCLOPHOSPHAMIDE, 10.1016/s0140-6736(84)92111-1
  30. Evelo C. T. A., Bos R. P., Peters J. G. P., Henderson P. Th., Urinary cyclophosphamide assay as a method for biological monitoring of occupational exposure to cyclophosphamide, 10.1007/bf00380766
  31. Sessink P. J. M., Boer K. A., Scheefhals A. P. H., Anzion R. B. M., Bos R. P., Occupational exposure to antineoplastic agents at several departments in a hospital : Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers, 10.1007/bf00381477
  32. Sessink P.J.M., Scholtes M.M., Anzion R.B.M., Bos R.P., Determination of cyclophosphamide in urine by gas chromatography—mass spectrometry, 10.1016/0378-4347(93)80404-r
  33. Sessink P.J.M., Cerná M., Rössner P., Pastorková A., Bavarová H., Franková K., Anzion R.B.M., Bos R.P., Urinary cyclophosphamide excretion and chromosomal aberrations in peripheral blood lymphocytes after occupational exposure to antieoplastic agents, 10.1016/0027-5107(94)90092-2
  34. Sessink Paul J. M., Van De Kerkhof Marc C. A., Anzion Rob B. M., Noordhoek Jan, Bos Rob P., Environmental Contamination and Assessment of Exposure to Antineoplastic Agents by Determination of Cyclophosphamide in Urine of Exposed Pharmacy Technicians: Is Skin Absorption an Important Exposure Route?, 10.1080/00039896.1994.9940377
  35. Ensslin Angela S., Pethran Angelika, Schierl Rudolf, Fruhmann G�nter, Urinary platinum in hospital personnel occupationally exposed to platinum-containing antineoplastic drugs, 10.1007/bf00405699
  36. Ensslin Angela S., Huber Reinhard, Pethran A., Römmelt Horst, Schierl Rudolf, Kulka Ulrike, Fruhmann Günter, Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: urinary excretion and cytogenetics studies, 10.1007/s004200050208
  37. Nygren O., Lundgren Cecilia, Determination of platinum in workroom air and in blood and urine from nursing staff attending patients receiving cisplatin chemotherapy, 10.1007/s004200050209
  38. Turci Roberta, Sottani Cristina, Ronchi Anna, Minoia Claudio, Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents, 10.1016/s0378-4274(02)00163-7
  39. Pethran A, Int Arch Occup Environ Health, 76, 5 (2003)
  40. Schreiber C, Int Arch Occup Environ Health, 76, 11 (2003)
  41. Sessink P. J. M., Kroese E. D., van Kranen H. J., Bos R. P., Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide, 10.1007/bf00385647
  42. Siderov Jim, Kirsa Sue, McLauchlan Robert, Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device, 10.1177/1078155209352543
  43. Sessink Paul JM, Connor Thomas H, Jorgenson James A, Tyler Timothy G, Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device, 10.1177/1078155210361431
  44. Nyman Heather, Jorgenson James, Slawson Matthew, Workplace Contamination with Antineoplastic Agents in a New Cancer Hospital Using a Closed-System Drug Transfer Device, 10.1310/hpj4203-219
  45. Yoshida J, Ann Occup Hyg, 53, 153 (2009)
  46. Connor TH, Am J Health Syst Pharm, 59, 68 (2002)
  47. Sessink PJM, Hosp Pharm, 34, 1311 (1999)
  48. Vandenbroucke Johan, Robays Hugo, How to protect environment and employees against cytotoxic agents, the UZ Ghent experience, 10.1177/107815520100600403
  49. Wick C, Am J Health Syst Pharm, 60, 2314 (2003)
  50. Clark Bernadette A, Sessink Paul JM, Use of a closed system drug-transfer device eliminates surface contamination with antineoplastic agents, 10.1177/1078155212468367
  51. Sessink Paul, Trahan Jason, Coyne Joseph, Reduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device, 10.1310/hpj4803-204